Trial Profile
An observational, prospective study investigating efficacy of denosumab in the treatment of patients with spinal cord injury related osteoporosis
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 10 Feb 2016
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 10 Feb 2016 New trial record